Preclinical News and Research

RSS
Threshold Pharmaceuticals reports $6.0M net loss for first-quarter 2010

Threshold Pharmaceuticals reports $6.0M net loss for first-quarter 2010

Cytori Therapeutics to initiate European medical device approval study for Celution System

Cytori Therapeutics to initiate European medical device approval study for Celution System

MicroStockProfit.com releases NexMed investment report

MicroStockProfit.com releases NexMed investment report

Two-day symposium on molecular neuroimaging

Two-day symposium on molecular neuroimaging

ADDF awards $210,300 to Amicus Therapeutics to evaluate PCs for treating Alzheimer's disease

ADDF awards $210,300 to Amicus Therapeutics to evaluate PCs for treating Alzheimer's disease

Resolvyx presents new data on RX-10001 for corneal herpes simplex virus infection at ARVO 2010

Resolvyx presents new data on RX-10001 for corneal herpes simplex virus infection at ARVO 2010

Amira Pharmaceuticals' LPA1 receptor antagonist program data published in British Journal of Pharmacology

Amira Pharmaceuticals' LPA1 receptor antagonist program data published in British Journal of Pharmacology

Tel Aviv researchers develop microscope-based cell scanner to speed research into fat-busting drugs

Tel Aviv researchers develop microscope-based cell scanner to speed research into fat-busting drugs

Abraxis Bioscience first-quarter ABRAXANE revenue increases to $87.9 million

Abraxis Bioscience first-quarter ABRAXANE revenue increases to $87.9 million

Curis reports net income of $4.8M for first-quarter 2010

Curis reports net income of $4.8M for first-quarter 2010

CombinatoRx reports $41.3M total revenue for first-quarter 2010

CombinatoRx reports $41.3M total revenue for first-quarter 2010

ArQule reports net loss of $9,752,000 for first-quarter 2010

ArQule reports net loss of $9,752,000 for first-quarter 2010

Vical reports net loss of $8.5 million for first-quarter 2010

Vical reports net loss of $8.5 million for first-quarter 2010

ViaCyte granted three new U.S. patents

ViaCyte granted three new U.S. patents

Cohera Medical reports top-line results from Tissuglu clinical trial

Cohera Medical reports top-line results from Tissuglu clinical trial

Intercell to acquire Cytos' platform technology for monoclonal antibody discovery

Intercell to acquire Cytos' platform technology for monoclonal antibody discovery

EpiCept provides update on corporate strategy, reports net loss of $4.5M for first-quarter 2010

EpiCept provides update on corporate strategy, reports net loss of $4.5M for first-quarter 2010

Alnylam Pharmaceuticals reports consolidated financial results for first quarter 2010

Alnylam Pharmaceuticals reports consolidated financial results for first quarter 2010

Novocell is now ViaCyte

Novocell is now ViaCyte

CPEX Pharmaceuticals reports record quarterly royalty revenues from Testim sales

CPEX Pharmaceuticals reports record quarterly royalty revenues from Testim sales

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.